dc.contributor.author | Altamimi, A-MS | en_US |
dc.contributor.author | Alafeefy, AM | en_US |
dc.contributor.author | Balode, A | en_US |
dc.contributor.author | Vozny, I | en_US |
dc.contributor.author | Pustenko, A | en_US |
dc.contributor.author | El Shikh, ME | en_US |
dc.contributor.author | Alasmary, FAS | en_US |
dc.contributor.author | Abdel-Gawad, SA | en_US |
dc.contributor.author | Žalubovskis, R | en_US |
dc.date.accessioned | 2018-02-08T11:36:40Z | |
dc.date.available | 2017-11-07 | en_US |
dc.date.issued | 2018-12 | en_US |
dc.date.submitted | 2017-12-08T12:53:01.530Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/32141 | |
dc.description.abstract | A series of symmetric molecules incorporating aryl or pyridyl moieties as central core and 1,4-substituted triazoles as a side bridge was synthesised. The new compounds were investigated as lactate dehydro-genase (LDH, EC 1.1.1.27) inhibitors. The cancer associated LDHA isoform was inhibited with IC50 = 117-174 µM. Seven compounds exhibited better LDHA inhibition (IC50 117-136 µM) compared to known LDH inhibitor - galloflavin (IC50 157 µM). | en_US |
dc.description.sponsorship | This project was supported by the National Plan of Science, Technology and Innovation [Grant No. 12-MED2980–54], Prince Sattam bin Abdulaziz University, Alkharj, PO Box 173, 11942. | |
dc.format.extent | 147 - 150 | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | J Enzyme Inhib Med Chem | en_US |
dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.subject | Lactate dehydrogenase | en_US |
dc.subject | inhibitors | en_US |
dc.subject | triazole | en_US |
dc.subject | Dose-Response Relationship, Drug | en_US |
dc.subject | Enzyme Inhibitors | en_US |
dc.subject | Humans | en_US |
dc.subject | Isocoumarins | en_US |
dc.subject | L-Lactate Dehydrogenase | en_US |
dc.subject | Molecular Structure | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.subject | Triazoles | en_US |
dc.title | Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A. | en_US |
dc.type | Article | |
dc.rights.holder | © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. | |
dc.identifier.doi | 10.1080/14756366.2017.1404593 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29199484 | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 33 | en_US |